Copyright Reports & Markets. All rights reserved.

Global Nuclear Medicine Diagnostic Equipment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nuclear Medicine Diagnostic Equipment Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 SPECT
    • 1.3.3 PET
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nuclear Medicine Diagnostic Equipment Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Tumor Imaging
    • 1.4.3 Bone Marrow Imaging
    • 1.4.4 Endocrine System Imaging
    • 1.4.5 Urinary System Imaging
    • 1.4.6 Others
  • 1.5 Global Nuclear Medicine Diagnostic Equipment Market Size & Forecast
    • 1.5.1 Global Nuclear Medicine Diagnostic Equipment Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Nuclear Medicine Diagnostic Equipment Sales Quantity (2021-2032)
    • 1.5.3 Global Nuclear Medicine Diagnostic Equipment Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 GE HealthCare
    • 2.1.1 GE HealthCare Details
    • 2.1.2 GE HealthCare Major Business
    • 2.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 GE HealthCare Recent Developments/Updates
  • 2.2 Siemens Healthineers
    • 2.2.1 Siemens Healthineers Details
    • 2.2.2 Siemens Healthineers Major Business
    • 2.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Siemens Healthineers Recent Developments/Updates
  • 2.3 Philips
    • 2.3.1 Philips Details
    • 2.3.2 Philips Major Business
    • 2.3.3 Philips Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.3.4 Philips Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Philips Recent Developments/Updates
  • 2.4 Mediso Medical Imaging Systems
    • 2.4.1 Mediso Medical Imaging Systems Details
    • 2.4.2 Mediso Medical Imaging Systems Major Business
    • 2.4.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.4.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Mediso Medical Imaging Systems Recent Developments/Updates
  • 2.5 Digirad
    • 2.5.1 Digirad Details
    • 2.5.2 Digirad Major Business
    • 2.5.3 Digirad Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.5.4 Digirad Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Digirad Recent Developments/Updates
  • 2.6 Toshiba
    • 2.6.1 Toshiba Details
    • 2.6.2 Toshiba Major Business
    • 2.6.3 Toshiba Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.6.4 Toshiba Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Toshiba Recent Developments/Updates
  • 2.7 Compañía Mexicana
    • 2.7.1 Compañía Mexicana Details
    • 2.7.2 Compañía Mexicana Major Business
    • 2.7.3 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.7.4 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Compañía Mexicana Recent Developments/Updates
  • 2.8 SurgicEye
    • 2.8.1 SurgicEye Details
    • 2.8.2 SurgicEye Major Business
    • 2.8.3 SurgicEye Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.8.4 SurgicEye Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 SurgicEye Recent Developments/Updates
  • 2.9 CMR Naviscan
    • 2.9.1 CMR Naviscan Details
    • 2.9.2 CMR Naviscan Major Business
    • 2.9.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.9.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CMR Naviscan Recent Developments/Updates
  • 2.10 DDD-Diagnostic
    • 2.10.1 DDD-Diagnostic Details
    • 2.10.2 DDD-Diagnostic Major Business
    • 2.10.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.10.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 DDD-Diagnostic Recent Developments/Updates
  • 2.11 Positron
    • 2.11.1 Positron Details
    • 2.11.2 Positron Major Business
    • 2.11.3 Positron Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.11.4 Positron Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Positron Recent Developments/Updates
  • 2.12 TeraRecon
    • 2.12.1 TeraRecon Details
    • 2.12.2 TeraRecon Major Business
    • 2.12.3 TeraRecon Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.12.4 TeraRecon Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 TeraRecon Recent Developments/Updates
  • 2.13 Neusoft Group
    • 2.13.1 Neusoft Group Details
    • 2.13.2 Neusoft Group Major Business
    • 2.13.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.13.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Neusoft Group Recent Developments/Updates
  • 2.14 United Imaging
    • 2.14.1 United Imaging Details
    • 2.14.2 United Imaging Major Business
    • 2.14.3 United Imaging Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.14.4 United Imaging Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 United Imaging Recent Developments/Updates
  • 2.15 MinFound Medical
    • 2.15.1 MinFound Medical Details
    • 2.15.2 MinFound Medical Major Business
    • 2.15.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.15.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 MinFound Medical Recent Developments/Updates
  • 2.16 SinoUnion Healthcare
    • 2.16.1 SinoUnion Healthcare Details
    • 2.16.2 SinoUnion Healthcare Major Business
    • 2.16.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.16.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 SinoUnion Healthcare Recent Developments/Updates
  • 2.17 Top Grade Healthcare
    • 2.17.1 Top Grade Healthcare Details
    • 2.17.2 Top Grade Healthcare Major Business
    • 2.17.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product and Services
    • 2.17.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Top Grade Healthcare Recent Developments/Updates

3 Competitive Environment: Nuclear Medicine Diagnostic Equipment by Manufacturer

  • 3.1 Global Nuclear Medicine Diagnostic Equipment Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Manufacturer (2021-2026)
  • 3.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Nuclear Medicine Diagnostic Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Nuclear Medicine Diagnostic Equipment Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Nuclear Medicine Diagnostic Equipment Manufacturer Market Share in 2025
  • 3.5 Nuclear Medicine Diagnostic Equipment Market: Overall Company Footprint Analysis
    • 3.5.1 Nuclear Medicine Diagnostic Equipment Market: Region Footprint
    • 3.5.2 Nuclear Medicine Diagnostic Equipment Market: Company Product Type Footprint
    • 3.5.3 Nuclear Medicine Diagnostic Equipment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nuclear Medicine Diagnostic Equipment Market Size by Region
    • 4.1.1 Global Nuclear Medicine Diagnostic Equipment Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Nuclear Medicine Diagnostic Equipment Consumption Value by Region (2021-2032)
    • 4.1.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Region (2021-2032)
  • 4.2 North America Nuclear Medicine Diagnostic Equipment Consumption Value (2021-2032)
  • 4.3 Europe Nuclear Medicine Diagnostic Equipment Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Nuclear Medicine Diagnostic Equipment Consumption Value (2021-2032)
  • 4.5 South America Nuclear Medicine Diagnostic Equipment Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Nuclear Medicine Diagnostic Equipment Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2021-2032)
  • 5.2 Global Nuclear Medicine Diagnostic Equipment Consumption Value by Type (2021-2032)
  • 5.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2021-2032)
  • 6.2 Global Nuclear Medicine Diagnostic Equipment Consumption Value by Application (2021-2032)
  • 6.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2021-2032)
  • 7.2 North America Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2021-2032)
  • 7.3 North America Nuclear Medicine Diagnostic Equipment Market Size by Country
    • 7.3.1 North America Nuclear Medicine Diagnostic Equipment Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Nuclear Medicine Diagnostic Equipment Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2021-2032)
  • 8.2 Europe Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2021-2032)
  • 8.3 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country
    • 8.3.1 Europe Nuclear Medicine Diagnostic Equipment Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Nuclear Medicine Diagnostic Equipment Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size by Region
    • 9.3.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2021-2032)
  • 10.2 South America Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2021-2032)
  • 10.3 South America Nuclear Medicine Diagnostic Equipment Market Size by Country
    • 10.3.1 South America Nuclear Medicine Diagnostic Equipment Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Nuclear Medicine Diagnostic Equipment Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Nuclear Medicine Diagnostic Equipment Market Size by Country
    • 11.3.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Nuclear Medicine Diagnostic Equipment Market Drivers
  • 12.2 Nuclear Medicine Diagnostic Equipment Market Restraints
  • 12.3 Nuclear Medicine Diagnostic Equipment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nuclear Medicine Diagnostic Equipment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nuclear Medicine Diagnostic Equipment
  • 13.3 Nuclear Medicine Diagnostic Equipment Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nuclear Medicine Diagnostic Equipment Typical Distributors
  • 14.3 Nuclear Medicine Diagnostic Equipment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nuclear Medicine Diagnostic Equipment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Nuclear medicine diagnosis mainly refers to nuclide imaging diagnosis, which can be divided into single photon emission computed tomography (SPECT) and positron emission computed tomography (PET) according to the different ways and types of radioactive elements used to emit gamma photons. Its principle is to inject single-photon/positron radioactive drugs into the human body, and then use SPECT or PET equipment to image the distribution of radionuclides, so as to analyze the function or metabolism of various organs to diagnose diseases. .
    In terms of the popularity and advancement of the product, SPECT was used clinically before PET, and the penetration rate is higher than that of PET, but the imaging effect of PET is clearer, the radiation damage to the human body is less, and it is more advanced than SPECT. In recent years, the development of PET The market is also growing faster. PET equipment is usually fused with CT and MRI to form PET/CT and PET/MR, and SPECT equipment is usually fused with CT to form SPECT/CT. Separate PET and SPECT equipment have gradually withdrawn from the market.
    Currently commonly used medical imaging methods include X-ray imaging, ultrasound imaging, CT, nuclear magnetic resonance MRI, SPECT/CT, PET/CT and PET/MR.
    This report is a detailed and comprehensive analysis for global Nuclear Medicine Diagnostic Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nuclear Medicine Diagnostic Equipment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Nuclear Medicine Diagnostic Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Nuclear Medicine Diagnostic Equipment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Nuclear Medicine Diagnostic Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nuclear Medicine Diagnostic Equipment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nuclear Medicine Diagnostic Equipment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare, Siemens Healthineers, Philips, Mediso Medical Imaging Systems, Digirad, Toshiba, Compañía Mexicana, SurgicEye, CMR Naviscan, DDD-Diagnostic, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Nuclear Medicine Diagnostic Equipment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    SPECT
    PET
    Market segment by Application
    Tumor Imaging
    Bone Marrow Imaging
    Endocrine System Imaging
    Urinary System Imaging
    Others
    Major players covered
    GE HealthCare
    Siemens Healthineers
    Philips
    Mediso Medical Imaging Systems
    Digirad
    Toshiba
    Compañía Mexicana
    SurgicEye
    CMR Naviscan
    DDD-Diagnostic
    Positron
    TeraRecon
    Neusoft Group
    United Imaging
    MinFound Medical
    SinoUnion Healthcare
    Top Grade Healthcare
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nuclear Medicine Diagnostic Equipment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nuclear Medicine Diagnostic Equipment, with price, sales quantity, revenue, and global market share of Nuclear Medicine Diagnostic Equipment from 2021 to 2026.
    Chapter 3, the Nuclear Medicine Diagnostic Equipment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nuclear Medicine Diagnostic Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nuclear Medicine Diagnostic Equipment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medicine Diagnostic Equipment.
    Chapter 14 and 15, to describe Nuclear Medicine Diagnostic Equipment sales channel, distributors, customers, research findings and conclusion.

    Buy now